Heparin-coating opens new chapter in stenting
This article was originally published in Clinica
The launch earlier this month of a heparin-coated stent by Medtronic opens a new chapter in the short, meteoric history of stenting. It promises to cut drastically the complications associated with stent implantation and free the patient from aggressive treatment with anticoagulant drugs.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.